Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SBAC✓SelectedUSD · SBACGSK vs SBAC performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs SBAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
SBAC return
+92.8%
Excess return
+9.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSBACExcessAlpha
1D-1.3%-0.7%-0.7%-1.2%
7D-3.1%-8.1%+5.0%-1.1%
30D-0.9%-4.7%+3.8%+0.2%
3M-4.2%-3.1%-1.1%-3.6%
6M-1.6%-13.0%+11.4%+1.3%
YTD+2.6%-8.0%+10.6%+3.4%
1Y+6.2%-9.9%+16.2%+7.7%
3Y+55.0%-20.8%+75.8%+60.6%
5Y+42.8%-45.1%+87.9%+60.1%
10Y+102.1%+91.3%+10.8%+80.2%
All+102.1%+92.8%+9.4%+80.2%

Cumulative growth

Daily Returns

Daily percentage return beside SBAC.

Daily Out/Under-Performance

Portfolio return minus SBAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling